Drugs & TargetsFree Keytruda receives accelerated approval from FDA for locally recurrent, unresectable or metastatic TNBC November 20, 2020Vol.46 No.44
Drugs & TargetsFree FDA issues draft guidance to provide important considerations in cross labeling of oncology drugs November 20, 2020Vol.46 No.44
Drugs & TargetsFree CDER and CBER to increase Emergency Use Authorization transparency November 20, 2020Vol.46 No.44
Drugs & TargetsFree Agendia and Paige collaborate on breast cancer research November 20, 2020Vol.46 No.44
Drugs & Targets FDA approves liquid biopsy NGS companion diagnostic test for multiple cancers and biomarkers November 13, 2020Vol.46 No.43
Drugs & Targets FDA issues guidance to enhance diversity in clinical trials, encourage inclusivity in medical product development November 13, 2020Vol.46 No.43
Drugs & Targets European Commission approves Opdivo + Yervoy with two cycles of chemotherapy for first-line treatment of metastatic NSCLC November 13, 2020Vol.46 No.43
Drugs & TargetsFree Lynparza approved in the EU as first-line maintenance treatment with bevacizumab for HRD-positive advanced ovarian cancer November 06, 2020Vol.46 No.42
Drugs & TargetsFree Kymriah receives approval for commercial manufacturing in Japan November 06, 2020Vol.46 No.42
